Archives for September 24, 2008

← 2008

Alpharma licenses transdermal delivery patch

By Nick Taylor

Alpharma has licensed an investigational transdermal bupivacaine patch from Durect for an initial $20m, with further payments based on reaching developmental milestones.

Moody's down on pharma prospects

By Phil Taylor

Pharmaceutical companies on both sides of the Atlantic are facing a particularly difficult time over the next 12 to 18 months, according to a report by financial research and analysis company Moody’s.

India’s Lupin buys into southern Africa

By Phil Taylor

Indian pharmaceutical company Lupin Ltd has expanded into Africa by acquiring a 60 per cent stake Pharma Dynamics, a generics company and contract manufacturer based in Cape Town, South Africa.

Melbourn offers integrated drug delivery service

By Nick Taylor

UK-based Melbourn Scientific is now offering an integrated package of formulation, method development, analysis and short-run clinical manufacture services to industrial clients.